Recordati and Sanofi Shares Rise Following $825 Million Drug Rights Deal
On Friday, Recordati, the Italian pharma group, said it would buy from Sanofi (NASDAQ: SNY) the global rights to a […]
Recordati and Sanofi Shares Rise Following $825 Million Drug Rights Deal Read More »